Valuation: Solventum Corporation

Market Cap 14.34B 13.06B 12.04B 10.95B 20.54B 1,328B 21.59B 147B 58.23B 725B 53.81B 52.68B 2,277B P/E 2026 *
74.3x
P/E 2027 * 19.7x
Enterprise Value 19.32B 17.6B 16.22B 14.75B 27.67B 1,789B 29.08B 197B 78.44B 977B 72.5B 70.97B 3,067B EV / Sales 2026 *
2.34x
EV / Sales 2027 * 2.18x
Free-Float
82.04%
Yield 2026 *
-
Yield 2027 * -
1 day-1.52%
1 week-5.14%
Current month+3.90%
1 month-2.19%
3 months-4.64%
6 months+10.99%
Current year+6.64%
1 week 84.13
Extreme 84.13
89.83
1 month 80.76
Extreme 80.76
93.1
Current year 62.38
Extreme 62.38
94.16
1 year 62.38
Extreme 62.38
94.16
3 years 47.16
Extreme 47.16
96.05
5 years 47.16
Extreme 47.16
96.05
10 years 47.16
Extreme 47.16
96.05
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Exercice

Chief Executive Officer

160,990 0.0930%
17/08/26 Free

Controller/Auditor

6,911 0.0040%
15/05/26 Free

Director

3,300 0.0019%
Change 5-day change 1-year change 3-year change Capi.($)
-1.52%-5.14%+6.28% - 14.56B
-0.84%-5.09%-16.92%+1.78% 180B
-0.67%-2.84%+0.59%+32.97% 123B
-0.98%+0.12%-14.00%+7.16% 119B
-1.24%-4.25%-43.89%-1.12% 89.18B
-0.63%-5.55%-6.35%+73.06% 65.12B
+0.05%-2.41%+12.24%-8.94% 57.93B
-1.95%-3.98%-1.91%+42.98% 54.33B
-2.91%-4.35%-0.82%+38.03% 48.88B
-1.64%+1.50%+2.30%-1.14% 36.07B
Average -1.23%-2.30%-6.25%+20.53% 79B
Weighted average by Cap. -1.05%-2.71%-10.44%+17.48%

Financials

2026 *2027 *
Net sales 8.25B 7.51B 6.92B 6.3B 11.81B 764B 12.42B 84.26B 33.49B 417B 30.95B 30.3B 1,309B 8.56B 7.8B 7.19B 6.54B 12.26B 793B 12.89B 87.45B 34.76B 433B 32.12B 31.45B 1,359B
Net income 200M 182M 168M 153M 287M 18.55B 302M 2.05B 813M 10.13B 752M 736M 31.8B 740M 674M 621M 565M 1.06B 68.53B 1.11B 7.56B 3B 37.43B 2.78B 2.72B 117B
Net Debt 4.98B 4.53B 4.18B 3.8B 7.13B 461B 7.49B 50.86B 20.21B 252B 18.68B 18.29B 790B 4.35B 3.96B 3.65B 3.32B 6.23B 403B 6.55B 44.42B 17.65B 220B 16.32B 15.97B 690B
Projected Income Statement - Annual - Solventum Corporation
Logo Solventum Corporation
Solventum Corporation specializes in the marketing of tools used in the medical field. Net sales break down by group of products as follows: - medical instruments and accessories (57.9%): for wound care, sterilization, surgery, etc.; - medical information systems (16.3%): primarily software solutions for documentation, billing, coding, data visualization, etc. in hospital settings; - dental and orthodontic instruments and accessories (16.2%): for dental care and restoration; - purification and filtration instruments (6%): used in the medical, bio-pharmaceutical, agri-food and other sectors; - other (3.6%). The United States accounts for 56.1% of net sales.
Employees
20,584
Date Price Change Volume
20/11/26 $84.50 -1.52% 658,399
19/11/26 $85.80 -0.79% 931,208
18/11/26 $86.48 +0.49% 764,910
17/11/26 $86.06 -2.92% 725,363
16/11/26 $88.65 -0.48% 848,112
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Solventum Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
84.50USD
Average target price
98.38USD
Spread / Average Target
+16.43%
  1. Stock Market
  2. Stocks
  3. SOLV Stock